A Study to Evaluate GSK Biologicals' Candidate Formulations of Pneumococcal Vaccines (GSK2189242A) in Young Adults.
Phase of Trial: Phase I
Latest Information Update: 12 May 2017
At a glance
- Drugs Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 06 Mar 2014 Results published in the Vaccine.
- 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History